IL-23 and IL-17 inhibition
Search documents
Alumis (NasdaqGS:ALMS) Update / Briefing Transcript
2026-01-06 14:02
Alumis (NasdaqGS:ALMS) Update / Briefing January 06, 2026 08:00 AM ET Company ParticipantsJohn Schroer - CFODerek Archila - Managing Director and Co-Head of Therapeutics ResearchMartin Babler - CEOJörn Drappa - CMOConference Call ParticipantsBrian Skorney - Senior Research AnalystYatin Suneja - Senior Managing Director and Biotechnology AnalystThomas Smith - Senior Research AnalystMitchell Kapoor - Director and Senior Biotechnology AnalystJeff Jones - Managing Director and Senior AnalystTerence Flynn - Equi ...